BI
THRD

BVF Inc’s Third Harmonic Bio THRD Stock Holding History

BVF Inc’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,372,933
Closed -$8.23M – 50
2025
Q1 		$8.23M Hold
2,372,933
– – 0.34% 36
2024
Q4 		$24.4M Sell
2,372,933
-1,993,000
-46% -$24.8M 0.83% 26
2024
Q3 		$59.2M Hold
4,365,933
– – 1.73% 16
2024
Q2 		$56.8M Hold
4,365,933
– – 1.59% 21
2024
Q1 		$41.2M Hold
4,365,933
– – 1.13% 26
2023
Q4 		$47.9M Hold
4,365,933
– – 1.2% 22
2023
Q3 		$27.9M Hold
4,365,933
– – 0.75% 29
2023
Q2 		$21M Hold
4,365,933
– – 0.59% 34
2023
Q1 		$18M Hold
4,365,933
– – 0.66% 38
2022
Q4 		$18.8M Buy
4,365,933
+864,119
+25% +$14.5M 0.79% 40
2022
Q3 		$66.4M Buy
+3,501,814
New +$63.1M 2.74% 12

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

BVF Inc's THRD Position: Q2 2025 in Review

BVF Inc sold out of Third Harmonic Bio (THRD) in Q2 2025, closing a stake of 2,372,933 shares — an estimated $8.23M sold.

BVF Inc first reported a position in THRD in Q3 2022 and held it in 11 quarters. The position peaked at $66.4M in Q3 2022. 106 funds tracked by Wall St. Rank hold THRD as of Q2 2025.

  • BVF Inc reported no remaining Third Harmonic Bio position as of Q2 2025 after selling out during the quarter.
  • BVF Inc sold 2,372,933 Third Harmonic Bio shares in Q2 2025, an estimated $8.23M.
  • BVF Inc first reported a position in Third Harmonic Bio in Q3 2022 and held it in 11 quarters.
  • BVF Inc's Third Harmonic Bio position peaked at $66.4M in Q3 2022.
  • 106 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q2 2025.

Based on BVF Inc's 13F filing for Q2 2025, filed 14 Aug 2025.